hoodb.com

昱展新藥(6785)ALA-1000於美國展開臨床III期前藥物動力學試驗 預計執行至2025年10月 (10/22日股價167.5元)

|

You are leaving and open the following URL" of about "ala" news

news.google.com/rss/articles/CBMibEFVX3lxTE5MWW1aLVFEenRiNGtTQmxPV2psUHE0NnVrNmkwNXJZd25ZSzJvbnhDcGhqNjE4Q2VPY3BSUWN0ZnI1ZTR5Zng3eFMwTlF5Z1lBTVZzOV9ZYTloVDR5VWlNMjRGTmlFVkZzVkEtdA?oc=5


Continue Opne >

ala: 昱展新藥(6785)ALA-1000於美國展開臨床III期前藥物動力學試驗 預計執行至2025年10月 (10/22日股價167.5元)


More ala news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/PT/ala.xml in /var/www/hoodb/function.php on line 339
1736516955-
Warning: file_put_contents(aCache/aaa/gnews/PT//ala.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About ala

from
1736516956-1736280959

Warning: filemtime(): stat failed for aCache/search/pt/ala in /var/www/hoodb/function.php on line 339
1736516956-

ala, 昱展新藥(6785)ALA-1000於美國展開臨床III期前藥物動力學試驗 預計執行至2025年10月 (10/22日股價167.5元) 2022 ala

昱展新藥(6785)ALA-1000於美國展開臨床III期前藥物動力學試驗 預計執行至2025年10月 (10/22日股價167.5元)

Choose Your Country or Region


Back to Top



昱展新藥(6785)ALA-1000於美國展開臨床III期前藥物動力學試驗 預計執行至2025年10月 (10/22日股價167.5元)

Copyright © 2020-2021 hoodb.com. All Rights Reserved.